Limitless Labs
Limitless Labs Raises $20M Series A for Physical AI in CNC Manufacturing
Limitless Labs announced $20M in Series A financing on June 16, 2026. Limitless Labs raised a $20 million Series A co-led by Dell Technologies Capital and Square Peg to build out a dedicated U.S. commercial organization and advance its Physical AI Foundation Model.
Round details
The financing includes backing from Dell Technologies Capital, Square Peg, Grove Ventures, Meron Capital. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: $20M
- Total funding reported: $27.3M
- Headquarters: Tel Aviv, Israel
How the company plans to use the capital
Limitless Labs said it will build out a dedicated U.S. commercial organization, advance its Physical AI Foundation Model toward closed-loop CNC automation, grow its CAM Agent, and expand its deep-tech research lab in Tel Aviv. The company said it expects to roughly double headcount over the next 12 months.
Why this matters for GTM teams
Limitless Labs says its CAM Agent works inside the CAD/CAM systems that engineers already use, including Mastercam, NX, and Creo, to help manufacturers automate key parts of CNC programming.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Limitless Labs Series A announcement.
Company Info
Investors (4)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


